Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Study of Recombinant Relaxin for Progressive Systemic Sclerosis

NCT00004380 is registered in ClinicalTrials.gov with National Center for Research Resources (NCRR) as lead sponsor.

NCT NCT00004380
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00004380 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Study of Recombinant Relaxin for Progressive Systemic Sclerosis
Lead sponsor
National Center for Research Resources (NCRR)
Phase
Phase 2
Overall status
Completed
Start date
December 31, 1991
Completion date
December 31, 1997
Enrollment
1
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

systemic sclerosis